These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6243043)

  • 41. Neuropeptides and brain development. Current perils and future potential.
    Swaab DF; Boer GJ
    J Dev Physiol; 1983 Apr; 5(2):67-75. PubMed ID: 6304180
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of the carboxyl-terminal tripeptide of vasopressin on plasma free fatty acids and cyclic adenosine monophosphate in man.
    Raij K; Härkönen M; Mulder J; Adlercreutz H
    Scand J Clin Lab Invest; 1975 May; 35(3):253-7. PubMed ID: 168631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The circadian and ultradian related periodicity of pituitary hormone secretion in man and rats (author's transl)].
    Kato Y; Katakami H; Shimatsu A; Matsushita N; Imura H; Hiroto S
    Tanpakushitsu Kakusan Koso; 1982 Jan; 27(2):233-45. PubMed ID: 6280239
    [No Abstract]   [Full Text] [Related]  

  • 44. [Variations in the contingent negative variation induced by administration of phenelzine and diazepam in normal adult subjects].
    Amabile G; Rizzo PA; Caporali M; Spadaro M; Zanasi M; Morocutti C
    Riv Neurol; 1978; 48(6):666-74. PubMed ID: 741166
    [No Abstract]   [Full Text] [Related]  

  • 45. [Psychotropic drugs, brain function and sleep. Neurophysiologic aspects of psychopharmacology and pharmacopsychiatry].
    Saletu B
    Bibl Psychiatr; 1976; (155):1-245. PubMed ID: 802167
    [No Abstract]   [Full Text] [Related]  

  • 46. Vasopressin and cerebral tiredness.
    Muscalu I; Constantinescu I
    Rev Roum Physiol; 1973; 10(2):160-75. PubMed ID: 4145418
    [No Abstract]   [Full Text] [Related]  

  • 47. Vasopressin in amnesia.
    Oliveros JC; Jandali MK; Timsit-Berthier M; Remy R; Benghezal A; Audibert A; Moeglen JM
    Lancet; 1978 Jan; 1(8054):42. PubMed ID: 74520
    [No Abstract]   [Full Text] [Related]  

  • 48. Vasopressin in amnesia.
    Blake DR; Dodd MJ; Evans JG
    Lancet; 1978 Mar; 1(8064):608. PubMed ID: 76146
    [No Abstract]   [Full Text] [Related]  

  • 49. A psychopharmacological perspective of cognitive functions. II. Specific pharmacologic agents.
    Wolkowitz OM; Tinklenberg JR; Weingartner H
    Neuropsychobiology; 1985; 14(3):133-56. PubMed ID: 2421196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasopressin and vasopressin analogues for treatment of memory disorders in clinical practice.
    Legros JJ; Timsit-Berthier M
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12 Suppl():S71-86. PubMed ID: 3074342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vasopressin-like peptides and the treatment of memory disorders in man.
    Jolles J
    Prog Brain Res; 1983; 60():169-82. PubMed ID: 6364210
    [No Abstract]   [Full Text] [Related]  

  • 52. Influence of vasopressin on learning and memory.
    Legros JJ; Gilot P; Seron X; Claessens J; Adam A; Moeglen JM; Audibert A; Berchier P
    Lancet; 1978 Jan; 1(8054):41-2. PubMed ID: 74519
    [No Abstract]   [Full Text] [Related]  

  • 53. Feeling cold: an unusual brain injury symptom and its treatment with vasopressin.
    Eames P
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):198-9. PubMed ID: 9048726
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of vasopressin on memory in healthy young adult volunteers. Theoretical and methodological issues.
    Beckwith BE; Petros TV; Couk DI; Tinius TP
    Ann N Y Acad Sci; 1990; 579():215-26. PubMed ID: 2337293
    [No Abstract]   [Full Text] [Related]  

  • 55. The purification and the amino acid content of vasopressin preparations.
    TURNER RA; PIERCE JG; du VIGNEAUD V
    J Biol Chem; 1951 Jul; 191(1):21-8. PubMed ID: 14850440
    [No Abstract]   [Full Text] [Related]  

  • 56. The use of pitressin in the treatment of schizophrenia with deterioration.
    FORIZS L
    N C Med J; 1952 Feb; 13(2):76-80. PubMed ID: 14911023
    [No Abstract]   [Full Text] [Related]  

  • 57. Central effects of vasopressin in man.
    Audibert A; Moeglen JM; Lancranjan I
    Int J Neurol; 1980; 14(2-4):162-74. PubMed ID: 6243043
    [No Abstract]   [Full Text] [Related]  

  • 58. Pituitary hormones and amnesia.
    Rigter H; Van Riezen H
    Curr Dev Psychopharmacol; 1979; 5():67-124. PubMed ID: 219989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormone-induced alteration in brain transmitter metabolism and brain function.
    Telegdy G
    Endocrinol Exp; 1982 Nov; 16(3-4):217-27. PubMed ID: 6129128
    [No Abstract]   [Full Text] [Related]  

  • 60. "Hormones that improve memory": a waiting game.
    Zoler ML
    Geriatrics; 1983 Jul; 38(7):101, 104-5. PubMed ID: 6303909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.